Prosight Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Prosight Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-176,900	Closed	-$4.86M	–	41
2024 Q4	$4.86M	Buy	+176,900	New	+$4.93M	1.36%	22
2024 Q1	–	Sell	-120,000	Closed	-$4.88M	–	46
2023 Q4	$4.88M	Buy	+120,000	New	+$4.42M	2.03%	15
2023 Q2	–	Sell	-40,000	Closed	-$1.55M	–	41
2023 Q1	$1.55M	Hold	40,000	–	–	0.74%	30
2022 Q4	$1.78M	Buy	+40,000	New	+$1.68M	0.99%	26
2022 Q2	–	Sell	-195,000	Closed	-$12.1M	–	29
2022 Q1	$12.1M	Sell	195,000 -5,300	-3%	-$324K	8.51%	4
2021 Q4	$11M	Buy	200,300 +100,300	+100%	+$5.23M	7.35%	4
2021 Q3	$5.26M	Buy	+100,000	New	+$5.94M	3.08%	12

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return